| Minimally Invasive Lung Adenocarcinoma studied in …STUDIED_INderived18 of 18show fewer |
|---|
| → studied in | NCT00334815Phase 2 · active not recruiting Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 18 trials mapped (4 active) | — | — | Minimally Invasive Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01386385Phase 1/Phase 2 · active not recruiting Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 18 trials mapped (4 active) | — | — | Minimally Invasive Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02186847Phase 2 · completed Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer · condition mapped PROBABILISTIC · 18 trials mapped (4 active) | — | — | Minimally Invasive Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03110978Phase 2 · active not recruiting Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 18 trials mapped (4 active) | — | — | Minimally Invasive Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 18 trials mapped (4 active) | — | — | Minimally Invasive Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00950365Phase 2 · completed Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer · condition mapped PROBABILISTIC · 18 trials mapped (4 active) | — | — | Minimally Invasive Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00126581Phase 2 · completed Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 18 trials mapped (4 active) | — | — | Minimally Invasive Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01294306Phase 2 · completed MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy · condition mapped PROBABILISTIC · 18 trials mapped (4 active) | — | — | Minimally Invasive Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00384826Phase 2 · completed Therapeutic Strategy in Advanced Bronchioloalveolar Carcinoma · condition mapped ALIAS · 18 trials mapped (4 active) | — | — | Minimally Invasive Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02239432unknown Telomere Biology in Early Adenocarcinoma of the Lung · condition mapped ALIAS · 18 trials mapped (4 active) | — | — | Minimally Invasive Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118144Phase 2 · completed Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer · condition mapped PROBABILISTIC · 18 trials mapped (4 active) | — | — | Minimally Invasive Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00369551Phase 1 · terminated Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer · condition mapped PROBABILISTIC · 18 trials mapped (4 active) | — | — | Minimally Invasive Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00029003Phase 2 · completed Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer · condition mapped PROBABILISTIC · 18 trials mapped (4 active) | — | — | Minimally Invasive Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00020709Phase 3 · completed Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery · condition mapped PROBABILISTIC · 18 trials mapped (4 active) | — | — | Minimally Invasive Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00021060Phase 2/Phase 3 · completed Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer · condition mapped PROBABILISTIC · 18 trials mapped (4 active) | — | — | Minimally Invasive Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00042835Phase 1 · terminated Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer · condition mapped PROBABILISTIC · 18 trials mapped (4 active) | — | — | Minimally Invasive Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00117351Phase 2 · terminated VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features · condition mapped ALIAS · 18 trials mapped (4 active) | — | — | Minimally Invasive Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00339586Phase 2 · unknown First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene · condition mapped ALIAS · 18 trials mapped (4 active) | — | — | Minimally Invasive Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |